X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (77) 77
oncology (76) 76
humans (75) 75
melanoma (70) 70
male (51) 51
melanoma - pathology (47) 47
female (46) 46
middle aged (44) 44
prognosis (39) 39
skin neoplasms - pathology (37) 37
surgery (34) 34
adult (32) 32
sentinel lymph node biopsy (32) 32
aged (31) 31
melanoma - surgery (31) 31
cutaneous melanoma (30) 30
metastasis (30) 30
survival (28) 28
biopsy (26) 26
lymphatic metastasis (24) 24
lymph node excision (22) 22
malignant-melanoma (22) 22
metastatic melanoma (22) 22
neoplasm staging (22) 22
cancer (19) 19
lymph nodes - pathology (19) 19
melanoma - mortality (19) 19
skin neoplasms - surgery (19) 19
metastases (18) 18
skin neoplasms - mortality (17) 17
follow-up studies (16) 16
lymph nodes (16) 16
retrospective studies (16) 16
sentinel node (15) 15
aged, 80 and over (14) 14
dissection (14) 14
melanoma - secondary (14) 14
analysis (13) 13
dermatology (13) 13
ipilimumab (13) 13
melanoma - diagnostic imaging (13) 13
sentinel lymph node biopsy - methods (13) 13
survival rate (13) 13
tumor burden (13) 13
ultrasonography (13) 13
ultrasound (13) 13
follow-up (12) 12
hematology, oncology and palliative medicine (12) 12
medicine & public health (12) 12
medicine, research & experimental (12) 12
adjuvant therapy (11) 11
surgical oncology (11) 11
young adult (11) 11
lymph nodes - diagnostic imaging (10) 10
lymphatic system (10) 10
patients (10) 10
risk factors (10) 10
tumors (10) 10
breast-cancer (9) 9
care and treatment (9) 9
diagnosis (9) 9
disease-free survival (9) 9
immunotherapy (9) 9
lymph nodes - surgery (9) 9
lymph-node (9) 9
melanoma - diagnosis (9) 9
melanoma - drug therapy (9) 9
prospective studies (9) 9
adolescent (8) 8
biopsy, fine-needle - methods (8) 8
clinical-relevance (8) 8
health aspects (8) 8
medical research (8) 8
melanomas (8) 8
multicenter (8) 8
criteria (7) 7
improved survival (7) 7
kaplan-meier estimate (7) 7
melanoma - therapy (7) 7
patient outcomes (7) 7
prognostic-factors (7) 7
skin neoplasms - therapy (7) 7
survival analysis (7) 7
american joint committee (6) 6
braf (6) 6
cohort studies (6) 6
lymph-nodes (6) 6
mek inhibition (6) 6
neoplasm recurrence, local - pathology (6) 6
neoplasm staging - methods (6) 6
netherlands - epidemiology (6) 6
predictive value of tests (6) 6
sensitivity and specificity (6) 6
sentinel node biopsy (6) 6
skin neoplasms - diagnosis (6) 6
toxicity (6) 6
treatment outcome (6) 6
clinical trials (5) 5
cytology (5) 5
early-stage melanoma (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Melanoma research, ISSN 0960-8931, 03/2019, Volume 29, Issue 4, pp. 358 - 364
In resected high-risk melanoma (stage IIB/C-III) the risk of locoregional and/or distant recurrence is substantial and so far adjuvant therapies have been... 
LYMPH-NODE DISSECTION | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | COMBINED NIVOLUMAB | adjuvant therapy | melanoma | OPEN-LABEL | DERMATOLOGY | INTERFERON-ALPHA | DABRAFENIB PLUS TRAMETINIB | RESECTED STAGE-III | ONCOLOGY | high-risk melanoma | CUTANEOUS MELANOMA | DOUBLE-BLIND | IPILIMUMAB
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 35, pp. 4227 - 4228
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1789 - 1801
A blinded trial involving patients with resected stage III melanoma showed that adjuvant pembrolizumab every 3 weeks for a year was associated with a 1-year... 
HIGH-RISK MELANOMA | SURVIVAL | MEDICINE, GENERAL & INTERNAL | ANTI-PD-1 THERAPY | EORTC 18952 | TUMOR BURDEN | CUTANEOUS MELANOMA | PHASE-3 TRIAL | PEGYLATED INTERFERON-ALPHA-2B | NODE-POSITIVE MELANOMA | IPILIMUMAB | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Adjuvants, Immunologic - adverse effects | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Adjuvants, Immunologic - therapeutic use | Skin Neoplasms - surgery | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Survival Rate | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Melanoma - drug therapy | Intention to Treat Analysis | Quality of Life | Aged | B7-H1 Antigen - analysis | Infusions, Intravenous | Melanoma - surgery | Neoplasm Staging | Melanoma - mortality | Diagnosis | Drug therapy | Patients | Health aspects | Melanoma | Medical research | Lymphatic system | Risk groups | PD-1 protein | Committees | Metastasis | Survival | Skin cancer | Pembrolizumab | Hospitals | Motivation | PD-L1 protein | Myositis | Death | Mutation | Tumors | Cancer | Index Medicus | Abridged Index Medicus | Placebos | Placebos (Medicine) | Adjuvant treatment of cancer | Tractament adjuvant del càncer
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2019
Background: Merkel cell carcinoma (MCC) is a rare and potentially lethal skin cancer. MCC is known for its potential rapid growth and its propensity to... 
The Netherlands | treatment | Merkel cell carcinoma | survival
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 2014, Volume 11, Issue 5, pp. 248 - 249
Journal Article
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 06/2019, Volume 45, Issue 6, pp. 1122 - 1123
Journal Article
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2019, Volume 145, Issue 4, pp. 974 - 978
Talimogene laherparepvec (T‐VEC) is a modified herpes simplex virus, type 1 (HSV‐1), which can be administered intralesionally in patients with stage... 
Talimogene Laherparepvec | melanoma | response evaluation | T‐VEC | oncolytic virus | immunotherapy | T-VEC | COLONY-STIMULATING FACTOR | ONCOLOGY | IMPROVED SURVIVAL | Medicine, Experimental | Medical research | Metastasis | Immunotherapy | Melanoma | Evaluation | Signs and symptoms | Toxicity | Medical services | Herpes simplex | Viruses | Disease control | Patients | Metastases | Influenza | Response rates | Oncolysis | Erythema
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2018, Volume 24, Issue 11, pp. 1655 - 1661
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2017, Volume 24, Issue S3, pp. 661 - 662
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1245/s10434-017-6230-7 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SENTINEL NODES | SURGERY | ONCOLOGY | CUTANEOUS MELANOMA | Usage | Melanoma | Metastasis | Index Medicus
Journal Article
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 8/2016, Volume 23, Issue 8, pp. 2586 - 2595
In open surgery procedures, after temporarily dimming the lights in the operation theatre, the Photo Dynamic Eye (PDE) fluorescence camera has, amongst others,... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | SENTINEL NODE BIOPSY | INDOCYANINE GREEN | TRACER | ONCOLOGY | TIME | MULTIMODAL SURGICAL GUIDANCE | IDENTIFICATION | CARCINOMA | CANCER | Fluorescence | Index Medicus | Head and Neck Oncology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.